Background Image
Table of Contents Table of Contents
Previous Page  333 / 492 Next Page
Information
Show Menu
Previous Page 333 / 492 Next Page
Page Background

15:26 - 15:29

S27-4

(PP)

THE USE OF ANTICHOLINERGIC MEDICATION IN BOYS WITH POSTERIOR

URETHRAL VALVES

Massimo GARRIBOLI, Aurora MARIANI, Arash TAGHIZADEH, Jo CLOTHIER, Kalpana PATIL and Anne WRIGHT

Evelina London Children's Hospital, Paediatric Nephro-Urology, London, UNITED KINGDOM

PURPOSE

To review the efficacy of Anticholinergic medication (AC) in boys with Posterior urethral valves (PUV) with particular

reference to urodynamic outcomes.

MATERIAL AND METHODS

Retrospective review of invasive (IUD) and non-ivasive (NIUD) urodynamics of PUV boys who were commenced on AC

between 2006 and 2015. Data presented as median (range).

RESULTS

Twenty boys, age 48.5 months (15-67), were commenced on AC for incontinence (n=10, 50%) and renal impairment

(n=10, 50%). In 14 IUD were available pre- and post-AC, in 5 a combination of IUD/NIUD and in 1 NIUD only, an

average of 7months (1-39) post AC commencement. Oxybutynin was used in 16, modified-release oxybutynin in 2 and

tolterodine in 2. Bladder capacity (BC) increased by an average of 75mls (p=0.004), and PVR by 40mls (p=0.17). Clean

Intermittent Catheterisation was used by 6 boys prior AC and required in a further 3 after AC was commenced.

Maximum detrusor overactive (max DO) pressure decreased by an average of 40cmH2O (p=0.001) and voiding max

pdet by 58cmH2O (p=0.007). Presence of vescicoureteric reflux was demonstrated in 8 renal units (n=6) before AC

treatment and only in 3 post AC.There was no significant change in detrusor pressure rise at end-fill (p det end-fill) or

post treatment serum creatinine. (See table). Continence parameters were improved in 6/10 (60%) boys. 1 boy each

reported constipation, difficulty initiating stream and abdominal pain.

Pre- and post-AC treatment

Pre(range)

Post(range)

P value

BC (mls)

135(24-327) 210(59-571) 0.004

Max DO (cm H2O)

56.8 (0-117) 16.9(0-59)

0.001

max p det (cm H2O)

123(83-229) 65(34-127)

0.007

p det end-fill (cm H2O) 14.7(0-40)

14.9(0-33)

0.9

PVR (mls)

25(0-70)

65(0-290)

0.17

Creatinine (umol/l)

117(28-439) 124(33-451) 0.09

CONCLUSIONS

AC in boys with PUV is associated with favourable improvements in urodynamic parameters, clinical status and

manageable adverse effects, however an increased PVR may necessitate commencement of CIC.